EUVIMEDEUVIMED entdecken
Kohortenstudie

Outcomes and prognostic factors for patients with Siewert type I/II esophagogastric junction adenocarcinoma following neoadjuvant chemotherapy and surgery: a Japanese cohort study

Masayoshi Terayama, Akihiko Okamura, Tomoyuki Irino, Kaoru Nakano, Naoki Takahashi, Jun Kanamori, Yu Imamura, Masaru Hayami, Motonari Ri, Souya Nunobe, Masayuki Watanabe

Surgery Today · 2026-11 · 56 (11) · 2782-2789

DOI: 10.1007/s00595-026-03418-6 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Surgery Today, online erschienen am 20.07.2026. Verfasst von Masayoshi Terayama und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-855…. Hauptthemen laut MEDLINE: Esophagogastric Junction, Adenocarcinoma, Neoadjuvant Therapy, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophagogastric JunctionAdenocarcinomaNeoadjuvant TherapyAntineoplastic Combined Chemotherapy ProtocolsEsophageal NeoplasmsStomach NeoplasmsHumansPrognosisFemaleRetrospective StudiesMaleTreatment OutcomeTegafurAgedMiddle AgedOxonic AcidCohort StudiesJapanNeoplasm StagingChemotherapy, AdjuvantDrug CombinationsCisplatinFluorouracilOxaliplatinDocetaxelCombined Modality Therapy

Stichwörter der Autor:innen

AdenocarcinomaAdvanced cancerEsophagogastric junctional cancerNeoadjuvant chemotherapy

Substanzen

TegafurOxonic AcidDrug CombinationsCisplatinFluorouracilS 1 (combination)OxaliplatinDocetaxelLeucovorin

Autor:innen und Institutionen

  • Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
  • Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan. akihiko.okamura@jfcr.or.jp.
  • Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

Zitieren

APA

Terayama, M., Okamura, A., Irino, T., Nakano, K., Takahashi, N., Kanamori, J., Imamura, Y., Hayami, M., Ri, M., Nunobe, S., & Watanabe, M. (2026). Outcomes and prognostic factors for patients with Siewert type I/II esophagogastric junction adenocarcinoma following neoadjuvant chemotherapy and surgery: a Japanese cohort study. Surgery Today, 56(11), 2782-2789. https://doi.org/10.1007/s00595-026-03418-6

Vancouver

Terayama M, Okamura A, Irino T, Nakano K, Takahashi N, Kanamori J, et al. Outcomes and prognostic factors for patients with Siewert type I/II esophagogastric junction adenocarcinoma following neoadjuvant chemotherapy and surgery: a Japanese cohort study. Surgery Today. 2026;56(11):2782-2789. doi:10.1007/s00595-026-03418-6

BibTeX
@article{Terayama2026,
  author = {Terayama, Masayoshi and Okamura, Akihiko and Irino, Tomoyuki and Nakano, Kaoru and Takahashi, Naoki and Kanamori, Jun and Imamura, Yu and Hayami, Masaru and Ri, Motonari and Nunobe, Souya and Watanabe, Masayuki},
  title = {Outcomes and prognostic factors for patients with Siewert type I/II esophagogastric junction adenocarcinoma following neoadjuvant chemotherapy and surgery: a Japanese cohort study},
  journal = {Surgery Today},
  year = {2026},
  volume = {56},
  number = {11},
  pages = {2782--2789},
  doi = {10.1007/s00595-026-03418-6}
}
Kostenlos starten →